7XS-19971-78281
2 vaccinations
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 051 / VT
- Registered
- 2022-08-28
- Relationship
- Child or adolescent in my care
- Guardian
- KJA-10831-15711
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-11
Dose 1 — Pfizer-BioNTech
-
2022-08-28
Registered in v-safe
- 2022-08-28
- 2022-09-01
-
2022-09-10
Survey response — day 28, dose 1, dependentMedDRA: Cough, Nasopharyngitis, Pyrexia, Respiratory tract congestion — Feeling: FairFree text: A general cold with fever, cough and congestion.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-15
Dose 2 — Pfizer-BioNTech
-
2022-09-17
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-11 | Pfizer-BioNTech | No |
| 2 | 2022-09-15 | Pfizer-BioNTech | No |
Free text
Release 12 — day 28, dose 1, dependent
Symptoms: A general cold with fever, cough and congestion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release